The information highlighted (if any) are the most recent updates for this brand.
Paxlovid is indicated for the treatment of COVID 19 in adults who do not require supplemental oxygen and who are at increased risk for progression to severe COVID 19 (see Pharmacology: Pharmacodynamics under Actions).